XML 19 R7.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock and paid-in capital
Accumulated earnings deficit
Accumulated other comprehensive income (loss)
Balance, beginning of period at Dec. 31, 2023   $ 939,339 $ 46,273 $ (1,988)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from exercise of equity awards and employee stock purchase plan   7,955    
Payment of withholding taxes related to net share settlement of equity awards   (67,515)    
Stock-based compensation expense   113,590    
Repurchase of common stock     (141,904)  
Net income (loss) $ (5,264)   (5,264)  
Foreign currency translation adjustment (3,658)     (3,658)
Change in net unrealized gain (loss) on marketable securities, net of tax       (2,305)
Balance, end of the period at Jun. 30, 2024 884,523 993,369 (100,895) (7,951)
Balance, beginning of period at Mar. 31, 2024   941,316 (11,820) (6,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from exercise of equity awards and employee stock purchase plan   6,769    
Payment of withholding taxes related to net share settlement of equity awards   (7,473)    
Stock-based compensation expense   52,757    
Repurchase of common stock     (99,908)  
Net income (loss) 10,833   10,833  
Foreign currency translation adjustment (684)     (684)
Change in net unrealized gain (loss) on marketable securities, net of tax       (494)
Balance, end of the period at Jun. 30, 2024 884,523 993,369 (100,895) (7,951)
Balance, beginning of period at Dec. 31, 2024 833,016 1,084,574 (245,206) (6,352)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from exercise of equity awards and employee stock purchase plan   5,369    
Payment of withholding taxes related to net share settlement of equity awards   (14,974)    
Stock-based compensation expense   109,529    
Repurchase of common stock     (129,957)  
Net income (loss) 66,782   66,782  
Excise tax on net stock repurchases     (840)  
Foreign currency translation adjustment 9,804     9,804
Change in net unrealized gain (loss) on marketable securities, net of tax       1,908
Balance, end of the period at Jun. 30, 2025 880,637 1,184,498 (309,221) 5,360
Balance, beginning of period at Mar. 31, 2025   1,128,164 (315,856) (1,610)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock from exercise of equity awards and employee stock purchase plan   5,302    
Payment of withholding taxes related to net share settlement of equity awards   (2,864)    
Stock-based compensation expense   53,896    
Repurchase of common stock     (29,993)  
Net income (loss) 37,052   37,052  
Excise tax on net stock repurchases     (424)  
Foreign currency translation adjustment 6,785     6,785
Change in net unrealized gain (loss) on marketable securities, net of tax       185
Balance, end of the period at Jun. 30, 2025 $ 880,637 $ 1,184,498 $ (309,221) $ 5,360